We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$4.71B
AUM Growth
+$53M
Cap. Flow
-$971M
Cap. Flow %
-20.64%
Top 10 Hldgs %
15.17%
Holding
850
New
129
Increased
145
Reduced
185
Closed
179

Sector Composition

Rank Sector Weight
1 Financials 25.53%
2 Technology 16.39%
3 Healthcare 9.58%
4 Industrials 6.86%
5 Consumer Discretionary 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTAQW
826
DELISTED
Carney Technology Acquisition Corp. II Warrant
CTAQW
-21,492
Closed -$1K
CTAQ
827
DELISTED
Carney Technology Acquisition Corp. II Class A Common Stock
CTAQ
-234,625
Closed -$2.4M
MIT
828
DELISTED
Mason Industrial Technology, Inc.
MIT
-28,456
Closed -$284K
CPARW
829
DELISTED
Catalyst Partners Acquisition Corp. Warrant
CPARW
-38,371
Closed
CPAR
830
DELISTED
Catalyst Partners Acquisition Corp. Class A Ordinary Share
CPAR
-420,329
Closed -$4.24M
PRBM
831
DELISTED
Parabellum Acquisition Corp.
PRBM
-215,625
Closed -$2.19M
SVFAW
832
DELISTED
SVF Investment Corp. Warrant
SVFAW
-17,000
Closed
JCIC
833
DELISTED
Jack Creek Investment Corp. Class A Ordinary Shares
JCIC
-88,044
Closed -$892K
ARCKW
834
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Warrants
ARCKW
-96,166
Closed -$4K
AEAC
835
DELISTED
Authentic Equity Acquisition Corp. Class A ordinary share
AEAC
-183,210
Closed -$1.85M
DLCA
836
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
-51,330
Closed -$518K
DLCAW
837
DELISTED
Deep Lake Capital Acquisition Corp. Warrant
DLCAW
-15,000
Closed
FINM
838
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
-65,428
Closed -$663K
FINMW
839
DELISTED
Marlin Technology Corporation Warrant
FINMW
-114,408
Closed
EPHYW
840
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
-214,000
Closed
POW
841
DELISTED
Powered Brands Class A Ordinary Shares
POW
-230,248
Closed -$2.33M
EPHY
842
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
-500,000
Closed -$5M
PACXW
843
DELISTED
Pioneer Merger Corp. Warrant
PACXW
-162,800
Closed
KAIR
844
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
-110,842
Closed -$1.12M
AILE
845
DELISTED
iLearningEngines, Inc. Common Stock
AILE
-122,000
Closed -$1.22M
STRE.WS
846
DELISTED
Supernova Partners Acquisition Company III, Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
STRE.WS
-84,408
Closed -$2K
PICC
847
DELISTED
Pivotal Investment Corporation III
PICC
-357,300
Closed -$3.62M
TIO
848
DELISTED
Tingo Group, Inc. Common Stock
TIO
-214,734
Closed -$178K

Similar funds

Cantor Fitzgerald's Q1 2023 Portfolio in Review

As of Q1 2023, Cantor Fitzgerald held 850 positions worth $4.71B, up 1.1% from $4.65B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Cantor Fitzgerald withdrew a net $971M in Q1 2023, closing 179 positions and reducing 185 holdings. Its most notable exit was AstraZeneca, an estimated $37.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Cantor Fitzgerald opened a new position in Zimmer Biomet worth $19.8M.

  • Cantor Fitzgerald's largest Q1 2023 buy was Zimmer Biomet: 153,493 shares worth $19.8M.
  • Cantor Fitzgerald added most to Battery Future Acquisition Corp. in Q1 2023, an estimated $28.6M increase.
  • Cantor Fitzgerald's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $935M.
  • Cantor Fitzgerald fully exited AstraZeneca in Q1 2023, selling an estimated $37.6M.
  • Cantor Fitzgerald's ten largest holdings make up 15% of its $4.71B portfolio in Q1 2023.
  • Cantor Fitzgerald opened 129 new positions and closed 179 in Q1 2023.
  • Cantor Fitzgerald's portfolio value rose 1.1% quarter-over-quarter to $4.71B.

Based on Cantor Fitzgerald's 13F filing for Q1 2023, filed 15 May 2023.